evidence card · follistatin_gene_therapy_aging
Follistatin gene therapy reduces aging or extends healthspan in humans
H1
? insufficient
stakes high
0 posts scored
·
across 0 accounts
·
1 sources
Summary
No peer-reviewed human RCT for aging outcomes. Self-experiments and small open-label work cannot support anti-aging claims. Gene therapy carries serious risks (immune, oncogenesis).
Five-score assessment
Scores not yet assigned for this card. (Legacy card; will be populated on next refinement.)
Scope
Population
humans
Intervention
follistatin gene therapy
Outcome
aging, healthspan, lifespan
Not supported for
- any clinical anti-aging claim in humans
Evidence sources
Sources
-
advisory FDA: human gene therapy oversight ↗
Account mentions
No accounts have made claims mapped to this card yet.